NCT04226885

Brief Summary

  • The preoperative time can be traumatic for young children undergoing surgery. Pediatric anesthesiologists act strongly to decrease distress for children in the operating room (OR) and to provide a smooth induction of anesthesia.
  • Many drugs have been used as premedication to decrease anxiety , facilitate smooth induction and easy separation of children from their parents.
  • This study was designed to evaluate and compare the effect and safety of nebulized either fentanyl, midazolam or nebulized dexmedetomidine as a sedative premedication prior to general anesthesia (GA) in outpatient pediatric dental surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

January 5, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 13, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2021

Completed
Last Updated

April 21, 2021

Status Verified

April 1, 2021

Enrollment Period

1.9 years

First QC Date

January 5, 2020

Last Update Submit

April 19, 2021

Conditions

Keywords

fentanyl ,midazolam, dexmeditomidine

Outcome Measures

Primary Outcomes (1)

  • of onset of sedation

    onset of sedation based on the Modified Observer's Assessment of Alertness/Sedation Scale 6Appears alert and awake, responds readily to name spoken in normal tone 5 Appears asleep but responds readily to name spoken in normal tone 4 Lethargic response to name spoken in normal tone 3 Responds only after name is called loudly or repeatedly 2 Responds only after mild prodding or shaking 1 Does not respond to mild prodding or shaking 0 Does not respond to noxious stimulus

    Baseline (before surgery)

Secondary Outcomes (2)

  • Heart rate

    Baseline (before surgery) and intraoperative

  • systolic and diastolic blood pressure

    Baseline (before surgery) and intraoperative

Study Arms (3)

fentanyl

ACTIVE COMPARATOR

patients will be given nebulized fentanyl 2μg/kg body weight 30 min before surgery

Drug: fentanyl

midazolam

ACTIVE COMPARATOR

The patients will be given nebulized midazolam 0.2 mg/kg body weight 30 min before surgery.

Drug: midazolam

dexmedetomidine

ACTIVE COMPARATOR

The patients will be given nebulized dexmedetomidine 2 μg/kg body weight 30 min before surgery.

Drug: dexmedetomidine

Interventions

nebulized fentanyl 2μg/kg body weigh

Also known as: fentanyl,
fentanyl

nebulized midazolam 0.2 mg/kg body weight 30 min before surgery.

Also known as: dormicum
midazolam

nebulized dexmedetomidine 2 μg/kg body weight 30 min before surgery.

Also known as: precedex
dexmedetomidine

Eligibility Criteria

Age2 Years - 6 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Parent acceptance.Children 2-6 years old of either sex.12-18 kg body weight. american society of anesthesiologist I-II.outpatients dental surgeries under general anesthesia.

You may not qualify if:

  • Difficult airway .central nervous system dysfunction.Advanced Cardiovascular ,liver, renal diseases. Allergy to the drugs under study. Patients with any intranasal pathology or congenital anomaly.Patient refusal to take the inhaled premeditation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine,Zagazig University

Zagazig, Zagazig, Elsharkia,egypt, 44519, Egypt

Location

MeSH Terms

Interventions

FentanylMidazolamDexmedetomidine

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsBenzodiazepinesBenzazepinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingImidazolesAzoles

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecture of anesthesia and surgical intensive care

Study Record Dates

First Submitted

January 5, 2020

First Posted

January 13, 2020

Study Start

March 1, 2019

Primary Completion

January 20, 2021

Study Completion

April 20, 2021

Last Updated

April 21, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will share

planned after completion of the study and publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
planned after completion of the study and publication
Access Criteria
contact after pricipal investigator

Locations